Fast growing but perhaps need to be more conservative - Mitarbeiter (anonym) bei BeOne: Mitarbeiterbewertung
4.0
14. Apr. 2019
Mitarbeiter (anonym)
Aktueller Mitarbeiter, weniger als 1 Jahr
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
really have some awesome pipelines
Kontras
grow too fast. the management should think about how to cut operation costs
Mehr Bewertungen zu BeOne entdecken
5.0
24. Apr. 2026
Mitarbeiter (anonym)
Aktueller Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
BeOne Medicines is building a strong reputation as a global oncology-focused company with a patient-centered approach. They’ve demonstrated the ability to advance innovative therapies across both hematologic malignancies and solid tumors, while also expanding their global footprint in clinical development. Their collaborative culture and emphasis on scientific rigor make them a compelling organization to work with and learn from.
Kontras
Fast timelines and global expansion may translate into heavy workload and urgency